Copertina

European expert consensus statement on the systemic treatment of alopecia areata

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	L. Rudnicka, M. Arenbergerova, R. Grimalt, D. Ioannides, A. C. Katoulis, E. Lazaridou, M. Olszewska, Y. S. Ovcharenko, B. M. Piraccini, A. Prohic, A. Rakowska, P. Reygagne, M. A. Richard, R. O. Soares, M. Starace, S. Vañó‐Galvan, A. Waskiel‐Burnat
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2024
Soggetti:	Journal of the European Academy of Dermatology and Venereology
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

A ranking of treatment efficacy in alopecia areata is not possible without head‐to‐head studies
di: Lidia Rudnicka, et al.
Pubblicazione: (2024)

Management of classic lichen planopilaris: The EADV task force on hair diseases position statement
di: Seyed Morteza Seyed Jafari, et al.
Pubblicazione: (2026)

Management of folliculitis decalvans: The EADV task force on hair diseases position statement
di: Anna Waśkiel‐Burnat, et al.
Pubblicazione: (2025)

Etrasimod for alopecia areata: The scenario for a less extensive and moderate form
di: M. Starace
Pubblicazione: (2025)

Lichen Planopilaris in Children: A Systematic Review
di: Małgorzata Papierzewska, et al.
Pubblicazione: (2024)

Delphi Consensus on the Distinct Clinical and Histopathological Features of Lichen Planopilaris and Frontal Fibrosing Alopecia: Insights From the Hair Diseases EADV Task Force
di: Michela Valeria Rita Starace, et al.
Pubblicazione: (2025)

Expert consensus for prevention, diagnosis and management of persistent chemotherapy‐induced alopecia
di: Azael Freites‐Martinez, et al.
Pubblicazione: (2025)

Strong efficacy of ritlecitinib 50 mg and baricitinib 4 mg in alopecia areata, but further research needed to establish superiority
di: David Saceda‐Corralo, et al.
Pubblicazione: (2025)

A new era for alopecia areata: New treatments and improved knowledge of the condition
di: Bianca Maria Piraccini
Pubblicazione: (2024)

Isotretinoin as a promising option in the treatment of facial papules of frontal fibrosing alopecia
di: Amir Mohammad Beyzaee, et al.
Pubblicazione: (2024)

Practical recommendations for seborrheic dermatitis management: An expert consensus
di: L. Naldi, et al.
Pubblicazione: (2026)

Diffuse pattern of alopecia areata in children: A multicentre retrospective study with 67 patients
di: Brenda Costa Buzatto, et al.
Pubblicazione: (2024)

Characterization of scalp, eyelash and eyebrow hair regrowth in patients with severe alopecia areata randomized to placebo in brave AA1 and brave AA2 trials
di: Abraham Zlotogorski, et al.
Pubblicazione: (2024)

A literature review and expert consensus statement on diagnostics in suspected metal implant allergy
di: P. Thomas, et al.
Pubblicazione: (2024)

Real‐life effectiveness and safety of baricitinib in adults with alopecia areata: A multicentre study
di: A. Mourtada, et al.
Pubblicazione: (2025)

Oral dutasteride is a first‐line treatment for frontal fibrosing alopecia
di: Sergio Vano‐Galvan, et al.
Pubblicazione: (2024)

Real‐life effectiveness and safety of baricitinib in patients with severe alopecia areata: A 24‐week Italian study
di: B. M. Piraccini, et al.
Pubblicazione: (2024)

Statement from the frontal fibrosing alopecia international expert alliance: SOFFIA 2024
di: Nekma Meah, et al.
Pubblicazione: (2025)

What is alopecia areata?
Pubblicazione: (2025)

Trichoscopy of Cicatricial Alopecia in Fair and Dark Skin: A Multicenter International Study of the EADV Task Force on Hair Diseases and the IDS Task Force on Trichoscopy
di: Awatef Kelati, et al.
Pubblicazione: (2026)

Comments on “Risk of autoimmune thyroid diseases in individuals with alopecia areata”
di: Brett R. Shaffer, et al.
Pubblicazione: (2025)

Long‐term safety and efficacy of ritlecitinib in adults and adolescents with alopecia areata and at least 25% scalp hair loss: Results from the ALLEGRO‐LT phase 3, open‐label study
di: C. Tziotzios, et al.
Pubblicazione: (2025)

International consensus statement on the use of ultrasound in hidradenitis suppurativa
di: X. Wortsman, et al.
Pubblicazione: (2025)

Efficacy and safety of etrasimod in alopecia areata: A multicentre, randomized, double‐blind, placebo‐controlled, Phase 2 study
di: B. King, et al.
Pubblicazione: (2025)

Patterns of misdiagnosis in adults with alopecia areata: an analysis using the NIH 's All of Us database
di: Courtney A. Chau, et al.
Pubblicazione: (2024)

Consensus statement on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: Localized scleroderma, systemic sclerosis and overlap syndromes
di: R. Knobler, et al.
Pubblicazione: (2024)

RETRACTED: Explore the genetic exposure to alopecia areata
di: Shaoyi Peng, et al.
Pubblicazione: (2024)

Long‐term efficacy and safety of baricitinib in patients with severe alopecia areata: 104‐week results from BRAVE‐AA1 and BRAVE‐AA2
di: M. Senna, et al.
Pubblicazione: (2024)

Effectiveness of dupilumab in the treatment of alopecia areata in patients with concurrent atopic dermatitis: a real‐life retrospective study
di: Gianluca Tavoletti, et al.
Pubblicazione: (2024)

Oral dutasteride can be considered a first‐line treatment for frontal fibrosing alopecia until high‐quality clinical trials could show better results with other therapies
di: S. Vano‐Galvan, et al.
Pubblicazione: (2025)

Radiopaque marker colonic transit study in the pediatric population BSPGHAN Motility Working Group consensus statement
di: M. Papadopoulos, et al.
Pubblicazione: (2024)

More than cosmetic: A personal perspective on alopecia areata and therapeutic restoration
di: Catherine S. Taghizadeh, et al.
Pubblicazione: (2026)

Line‐field confocal optical coherence tomography in alopecia areata and histopathological correlation
di: Emanuele Trovato, et al.
Pubblicazione: (2024)

Health‐related quality of life of adult and adolescent patients living with alopecia areata in Australia
di: Rodney Sinclair, et al.
Pubblicazione: (2024)

Corrigendum to ‘A literature review and expert consensus statement on diagnostics in suspected metal implant allergy’
Pubblicazione: (2024)

The impact of alopecia areata on patients' daily lives: A study using social media in France
di: S. Barbarot, et al.
Pubblicazione: (2024)

Patient satisfaction with multidisciplinary shared medical appointments for alopecia areata and frontal fibrosing alopecia
di: Ogechi Ezemma, et al.
Pubblicazione: (2024)

Successful treatment of alopecia areata‐associated trachyonychia with baricitinib
di: Petra Rózsa, et al.
Pubblicazione: (2024)

Tick bite‐induced alopecia areata‐like effluvium
di: Rodrigo Peñuelas Leal, et al.
Pubblicazione: (2024)

Update on pulse corticosteroid therapy for the management of alopecia areata
di: Jolina Bernhardt, et al.
Pubblicazione: (2024)